03:13 AM EDT, 08/26/2024 (MT Newswires) -- Sharon Mates, Director, Chairman and Chief Executive Officer, on August 21, 2024, sold 121,073 shares in Intra-Cellular Therapies ( ITCI ) for $9,086,738. Following the Form 4 filing with the SEC, Mates has control over a total of 1,070,329 shares of the company, with 1,070,329 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1567514/000095017024100275/xslF345X05/ownership.xml